Neiraxin B (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride, Lidocaine Hydrochloride)

Each vitamin acts as a co‑factor for essential metabolic pathways: thiamine supports carbohydrate metabolism, pyridoxine assists amino‑acid and neurotransmitter synthesis, and cyanocobalamin is required for DNA synthesis and red‑cell formation. Lidocaine blocks sodium channels, preventing nerve impulse transmission and producing temporary numbness at the injection site.

The dosage of Neiraxin B is determined by the prescribing healthcare professional based on the patient’s clinical condition, vitamin status and procedural requirements. Only a qualified prescriber should set the appropriate dose and administration schedule.

Safety data for Neiraxin B in pregnancy and lactation are limited. The benefits and risks should be evaluated by the treating physician. Generally, vitamin B supplementation may be indicated, but lidocaine exposure should be considered carefully, especially in the first trimester.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Neiraxin B combines three B‑vitamins with a local anesthetic in a single intramuscular formulation, offering both deficiency correction and immediate pain control. Other vitamin B injections may contain only one or two vitamins and lack an anesthetic, requiring separate analgesia for painful administrations.

Neiraxin B should be stored at ambient temperature, protected from direct sunlight, moisture and extreme heat. Keep the vial in its original packaging until use and avoid freezing. Inspect the product for particulate matter before administration.

Neiraxin B is given by intramuscular injection into a suitable muscle group, typically the deltoid or gluteal region. The injection should be performed by a qualified healthcare professional using aseptic technique and appropriate needle size.

Serious risks include severe allergic reactions such as anaphylaxis, cardiovascular collapse or arrhythmias from lidocaine toxicity, and rare hematologic disorders like methemoglobinemia. Immediate medical attention is required if any of these symptoms occur.

Neiraxin B is contraindicated in individuals with known hypersensitivity to any of its components, especially lidocaine, or in patients with severe hepatic or renal impairment where vitamin metabolism is compromised. It should also be avoided in patients with certain cardiac conduction disorders when high doses of lidocaine are used.